Grail's (GRAL) stock is dropping 6% after the company reported fourth-quarter revenue above analysts' average estimate and noted that Tricare, a large health insurance provider, had decided to ...

Grail (GRAL) is rallying 15% and set a new all-time high after Quest Diagnostics (DGX) and GRAL announced earlier today that they had made a deal. Grail provides Galleri, a blood test that detects ...

I'm glad to be partnering with GRAIL on Generation Possible to help others understand the possibilities of MCED testing." MCED tests are a new screening tool for multiple cancers that do not have ...

GRAIL's promise of revolutionising cancer blood testing attracted the attention of major investors, accruing $1 billion in funding from the likes of Alphabet, Amazon and Bill Gates.